ArticleFrontiers in oncology2026

Recurrent severe thrombocytopenia induced by anti-HER2 therapy in a breast cancer patient with an underlying immune disorder: a case report and literature review.

Bo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.